Halozyme(HALO) - 2025 Q2 - Earnings Call Presentation

Halozyme Therapeutics, Inc. Second Quarter Financial & Operating Results NASDAQ: HALO August 5, 2025 1 Forward-Looking Statements In addition to historical information, the statements set forth in this presentation include forward-looking statements including, without limitation, statements concerning the Company's expected future financial performance and growth rates (including the Company's 2025 financial guidance and longer term financial outlook through 2028 and the assumptions used in deriving such gu ...